Trane Technologies shareholder plans sale of 2,389 shares

Trane Technologies shareholder plans to sell 2,389 common shares through UBS Financial Services Inc. on or about February 10, 2026 on the NYSE.

Rhea-AI Filing Summary

Trane Technologies shareholder plans to sell 2,389 common shares through UBS Financial Services Inc. on or about February 10, 2026 on the NYSE. The filing lists an aggregate market value of 1101099.84 for these shares, compared with 221,331,905 common shares outstanding.

The shares to be sold match recent awards of restricted stock units, with 831, 768, and 790 common shares acquired from the issuer on February 4, 6, and 7, 2026, respectively. The seller represents that they are not aware of any undisclosed material adverse information about the company.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Trane Technologies (TT) Form 144 filing disclose?

The Form 144 filing discloses a planned sale of 2,389 common shares of Trane Technologies. The shares are to be sold through UBS Financial Services on the NYSE, with an aggregate stated market value of 1101099.84 at the time of the notice.

How many Trane Technologies (TT) shares are being registered for sale?

The filing covers a planned sale of 2,389 common shares of Trane Technologies. These shares correspond to restricted stock units acquired from the issuer on three dates in February 2026, and are listed with a combined aggregate market value of 1101099.84.

How were the Trane Technologies (TT) shares in the Form 144 acquired?

The shares were acquired as restricted stock units (RSUs) from the issuer. The filing shows acquisitions of 831, 768, and 790 common shares on February 4, 6, and 7, 2026, respectively, all identified as RSU transactions with the issuer.

What does the Form 144 say about Trane Technologies (TT) outstanding shares?

The notice states that Trane Technologies has 221,331,905 common shares outstanding. This figure provides context for the planned sale of 2,389 shares, showing the transaction is small relative to the total outstanding share count reported in the document.

Which broker will handle the Trane Technologies (TT) share sale?

The planned sale will be handled by UBS Financial Services Inc., listed at 11 Madison Avenue, 4th Floor, New York, NY 10010. The filing indicates the shares are expected to be sold on the NYSE around February 10, 2026.

Does the Trane Technologies (TT) seller claim to know any undisclosed bad news?

The person for whose account the shares are to be sold represents that they do not know of any material adverse information about Trane Technologies’ current or prospective operations that has not been publicly disclosed, as required in the representation section of the notice.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/10/2026 - 04:06 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001546645
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Trane Technologies plc
SEC File Number	001-34400
Address of Issuer	170/175 LAKEVIEW DRIVE AIRSIDE BUSINESS PARK, SWORDS, CO. DUBLIN IRELAND 00000
Phone	732-652-7000
Name of Person for Whose Account the Securities are To Be Sold	Kuehn Christopher J
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services Inc. 11 Madison Avenue 4th Floor New York NY 10010	2389	1101099.84	221331905	02/10/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/04/2026	RSU	Issuer			831	02/04/2026	N/A
Common	02/06/2026	RSU	Issuer			768	02/06/2026	N/A
Common	02/07/2026	RSU	Issuer			790	02/07/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	02/10/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	10/31/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ UBS Financial Services Inc, as attorney-in-fact for Christopher Kuehn
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)